October 2019 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- Building A $1 Billion Gene Therapy Company — In 6 Years
- Impact Investing — The Next BIG Thing In Life Sciences?
Capitol Perspectives
CEO Corner
From Principles and Policy to Execution
Companies To Watch
Industry Research
Inside The Industry
- Potential Solutions To Current Pricing Models For Cell And Gene Therapies
- Regulators Emphasize Patience In Tailored Biosimilar Development
- Areas Of Growth For Oral-Dose Outsourcing
- Program Winners Look Back On Year Of Change
- Taking A Strengths-Based Approach To Diversity & Inclusion
Leadership Lessons
Ask The Board
- What Is The Most Ridiculous Justification You Have Ever Heard To Rationalize An Inefficient /Expensive Capital Structure?
- What Was The Most Valuable Experience/Training That Prepared You For The Role Of CFO?
- What Advice Do You Have For Women Interested In Becoming Senior-Level Leaders And Serving On Corporate Boards Of Biopharma Companies?
This website uses cookies to ensure you get the best experience on our website. Learn more